Category
Category: Gene & Cell therapy
Ensuring Viral Vector Supply for Gene Therapies
From Big Pharma to Startup CEO: Lessons from Kymriah Developer Gaurav Shah
What Factors can Ease the Complexity of Viral Vector Production for Gene Therapies?
Why Are There Only 11 Cell and Gene Therapies in Europe?
T-Cell Therapy Firm Wins Massive €93M Series A to Treat Solid Tumors
Why a US Presence Can Help European Biotechs Get Ahead
Record Funding for Gene and Cell Therapy Accompanies Turbulent Times
Covid-19 Forces Gene Therapy Companies to Shift Strategy
Sanofi Enlists Cell Therapy Firm Kiadis in €875M Immuno-Oncology Deal
The Three Obstacles Stopping Cell Therapy Becoming Mainstream
